{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T06:02:26Z","timestamp":1791093746663,"version":"4.1.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2009,2,19]],"date-time":"2009-02-19T00:00:00Z","timestamp":1235001600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2009,5]]},"DOI":"10.1245\/s10434-009-0357-0","type":"journal-article","created":{"date-parts":[[2009,2,18]],"date-time":"2009-02-18T15:05:22Z","timestamp":1234969522000},"page":"1324-1330","source":"Crossref","is-referenced-by-count":122,"title":["Surgery for Recurrent Ovarian Cancer: Role of Peritoneal Carcinomatosis: Exploratory Analysis of the DESKTOP I Trial About Risk Factors, Surgical Implications, and Prognostic Value of Peritoneal Carcinomatosis"],"prefix":"10.1245","volume":"16","author":[{"given":"P.","family":"Harter","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Hahmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. J.","family":"Lueck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Poelcher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Wimberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.","family":"Ortmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"U.","family":"Canzler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Richter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"U.","family":"Wagner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Hasenburg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Burges","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Loibl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.","family":"Meier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Huober","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Fink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.","family":"Schroeder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Muenstedt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Schmalfeldt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Emons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"du Bois","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,2,19]]},"reference":[{"key":"357_CR1","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1002\/(SICI)1097-0142(20000101)88:1<144::AID-CNCR20>3.0.CO;2-X","volume":"88","author":"SM Eisenkop","year":"2000","unstructured":"Eisenkop SM, Friedman RL, Spirtos NM. The role of secondary cytoreductive surgery in the treatment of patients with recurrent epithelial ovarian carcinoma. Cancer. 2000;88:144\u201353.","journal-title":"Cancer"},{"key":"357_CR2","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.ejso.2004.08.016","volume":"31","author":"B Gronlund","year":"2005","unstructured":"Gronlund B, Lundvall L, Christensen IJ, et al. Surgical cytoreduction in recurrent ovarian carcinoma in patients with complete reponse to paclitaxel-platinum. Eur J Surg Oncol. 2005;31:67\u201373.","journal-title":"Eur J Surg Oncol"},{"key":"357_CR3","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1002\/1097-0142(19921015)70:8<2129::AID-CNCR2820700820>3.0.CO;2-U","volume":"70","author":"F Jaenicke","year":"1992","unstructured":"Jaenicke F, Holscher M, Kuhn W, et al. Radical surgery procedure improves survival time in patients with recurrent ovarian cancer. Cancer. 1992;70:2129\u201336.","journal-title":"Cancer"},{"key":"357_CR4","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.ygyno.2004.07.033","volume":"95","author":"MM Leitao","year":"2004","unstructured":"Leitao MM, Kardos S, Barakat RR, Chi DS. Tertiary cytoreduction in patients with recurrent ovarian cancer. Gynecol Oncol. 2004;95:181\u20135.","journal-title":"Gynecol Oncol"},{"key":"357_CR5","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1006\/gyno.2001.6404","volume":"83","author":"C Scarabelli","year":"2001","unstructured":"Scarabelli C, Gallo A, Carbone A. Secondary cytoreductive surgery for patients with recurrent epithelial ovarian carcinoma. Gynecol Oncol. 2001;83:504\u201312.","journal-title":"Gynecol Oncol"},{"key":"357_CR6","first-page":"1008","volume":"99","author":"EH Tay","year":"2002","unstructured":"Tay EH, Grant PT, Gebski V, Hacker NF. Secondary cytoreductive surgery for recurrent epithelial ovarian cancer. Obstet Gynecol. 2002;99:1008\u201313.","journal-title":"Obstet Gynecol"},{"key":"357_CR7","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1002\/cncr.20106","volume":"100","author":"RY Zang","year":"2004","unstructured":"Zang RY, Li ZT, Tang J, et al. Secondary cytoreductive surgery for patients with relapsed epithelial ovarian carcinoma: who benefits? Cancer. 2004;100:1152\u201361.","journal-title":"Cancer"},{"key":"357_CR8","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1245\/s10434-006-9273-8","volume":"14","author":"P Benedetti Panici","year":"2007","unstructured":"Benedetti Panici P, De Vivo A, Bellati F, et al. Secondary cytoreductive surgery in patients with platinum-sensitive recurrent ovarian cancer. Ann Surg Oncol. 2007;14:1136\u201342.","journal-title":"Ann Surg Oncol"},{"key":"357_CR9","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1245\/s10434-006-9058-0","volume":"13","author":"P Harter","year":"2006","unstructured":"Harter P, du Bois A, Hahmann M, et al. Surgery in recurrent ovarian cancer: the Arbeitsgemeinschaft Gynaekologische Onkologie (AGO) DESKTOP OVAR Trial. Ann Surg Oncol. 2006;13:1702\u201310.","journal-title":"Ann Surg Oncol"},{"key":"357_CR10","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1002\/cncr.21845","volume":"106","author":"DS Chi","year":"2006","unstructured":"Chi DS, McCaughty K, Diaz JP, et al. Guidelines and selection criteria for secondary cytoreductive surgery in patients with recurrent platinum-sensitive epithelial ovarian carcinoma. Cancer. 2006;106:1933\u20139.","journal-title":"Cancer"},{"key":"357_CR11","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1046\/j.1525-1438.2002.01171.x","volume":"12","author":"U Saygili","year":"2002","unstructured":"Saygili U, Guclu S, Uslu T, Erten O, Dogan E. The effect of ascites, mass volume, and peritoneal carcinomatosis on serum CA125 levels in patients with ovarian carcinoma. Int J Gynecol Cancer. 2002;12:438\u201342.","journal-title":"Int J Gynecol Cancer"},{"key":"357_CR12","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1055\/s-2003-41864","volume":"125","author":"J Sehouli","year":"2003","unstructured":"Sehouli J, K\u00f6nsgen D, Mustea A, et al. IMO\u2014intraoperative mapping of ovarian cancer. Zentralbl Gynakol. 2003;125:129\u201335.","journal-title":"Zentralbl Gynakol"},{"key":"357_CR13","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1006\/gyno.2001.6313","volume":"82","author":"SM Eisenkop","year":"2001","unstructured":"Eisenkop SM, Spirtos NM. Procedures required to accomplish complete cytoreduction of ovarian cancer: is there a correlation between \u201cbiological aggressiveness\u201d and survival? Gynecol Oncol. 2001;82:435\u201341.","journal-title":"Gynecol Oncol"},{"key":"357_CR14","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1006\/gyno.2001.6312","volume":"82","author":"SM Eisenkop","year":"2001","unstructured":"Eisenkop SM, Spirtos NM. What are the current surgical objectives, strategies, and technical capabilities of gynecologic oncologists treating advanced epithelial ovarian cancer. Gynecol Oncol. 2001;82:489\u201397.","journal-title":"Gynecol Oncol"},{"key":"357_CR15","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1097\/01.cco.0000174166.06734.c7","volume":"17","author":"P Harter","year":"2005","unstructured":"Harter P, du Bois A. The role of surgery in ovarian cancer with special emphasis on cytoreductive surgery for recurrence. Curr Opin Oncol. 2005;17:505\u201314.","journal-title":"Curr Opin Oncol"},{"key":"357_CR16","doi-asserted-by":"crossref","unstructured":"Parmar MK, Lederman JA, Colombo N, et al. Paclitaxel plus platinum-based chemotherapy versus conventional platinum-based chemotherapy in women with relapsed ovarian cancer: the ICON4\/AGO-OVAR-2.2 trial. Lancet. 2003;361:2099\u2013106.","DOI":"10.1016\/S0140-6736(03)13718-X"},{"key":"357_CR17","doi-asserted-by":"crossref","first-page":"4699","DOI":"10.1200\/JCO.2006.06.0913","volume":"24","author":"J Pfisterer","year":"2006","unstructured":"Pfisterer J, Plante M, Vergote I, et al. Gemcitabine plus carboplatin compared with carboplatin in patients with platinum-sensitive recurrent ovarian cancer: an intergroup trial of the AGO-OVAR, the NCIC CTG, and the EORTC GCG. J Clin Oncol. 2006;24:4699\u2013707.","journal-title":"J Clin Oncol"},{"key":"357_CR18","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1200\/JCO.2002.20.5.1248","volume":"20","author":"RE Bristow","year":"2002","unstructured":"Bristow RE, Tomacruz RS, Armstrong DK, Trimble EL, Montz FJ. Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis. J Clin Oncol. 2002;20:1248\u201359.","journal-title":"J Clin Oncol"},{"key":"357_CR19","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.ygyno.2007.02.026","volume":"106","author":"P Wimberger","year":"2007","unstructured":"Wimberger P, Lehmann N, Kimmig R, et al. Prognostic factors for complete debulking in advanced ovarian cancer and its impact on survival. An exploratory analysis of a prospectively randomized phase III study of the Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group (AGO-OVAR). Gynecol Oncol. 2007;106:69\u201374.","journal-title":"Gynecol Oncol"},{"issue":"8","key":"357_CR20","doi-asserted-by":"crossref","first-page":"viii7","DOI":"10.1093\/annonc\/mdi961","volume":"16","author":"A du Bois","year":"2005","unstructured":"du Bois A, Quinn M, Thigpen T, et al. Consensus statements on the management of ovarian cancer: final document of the 3rd International Gynecologic Cancer Intergroup Ovarian Cancer Consensus Conference (GCIG OCCC 2004). Ann Oncol. 2005;16(Suppl 8):viii7\u201312.","journal-title":"Ann Oncol"},{"key":"357_CR21","doi-asserted-by":"crossref","first-page":"3621","DOI":"10.1200\/JCO.2006.10.2517","volume":"25","author":"WE Winter III","year":"2007","unstructured":"Winter III WE, Maxwell GL, Tian CT, et al. Prognostic factors for stage III epithelial ovarian cancer: a Gynecologic Oncology Group study. J Clin Oncol. 2007;25:3621\u20137.","journal-title":"J Clin Oncol"},{"key":"357_CR22","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1038\/sj.bjc.6602466","volume":"92","author":"T Onda","year":"2005","unstructured":"Onda T, Yoshikawa H, Yasugi T, Yamada M, Matsumoto K, Taketani J. Secondary cytoreductive surgery for recurrent epithelial ovarian carcinoma: proposal for patients selection. Br J Cancer. 2005;92:1026\u201332.","journal-title":"Br J Cancer"},{"key":"357_CR23","doi-asserted-by":"crossref","unstructured":"Oksefjell H, Sandstad B, Trop\u00e9 C. The role of secondary cytoreduction in the management of the first relapse in epithelial ovarian cancer. Ann Oncol (in press) 25 August 2008 (Epub ahead of print).","DOI":"10.1093\/annonc\/mdn591"},{"key":"357_CR24","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/S0090-8258(03)00278-6","volume":"90","author":"SM Eisenkop","year":"2003","unstructured":"Eisenkop SM, Spirtos NM, Friedman RL, et al. Relative influences of tumor volume before surgery and the cytoreductive outcome on survival for patients with advanced ovarian cancer: a prospective study. Gynecol Oncol. 2003;90:390\u20136.","journal-title":"Gynecol Oncol"},{"key":"357_CR25","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.1016\/j.ejca.2006.03.025","volume":"42","author":"G Ferrandina","year":"2006","unstructured":"Ferrandina G, Legge F, Salutari V, et al. Impact of pattern of recurrence on clinical outcome of ovarian cancer patients: clinical considerations. Eur J Cancer. 2006;42:2296\u2013302.","journal-title":"Eur J Cancer"},{"key":"357_CR26","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1055\/s-2008-1046914","volume":"152","author":"R Lorenz","year":"1990","unstructured":"Lorenz R, Krestin GP, Schmitz-Rixen T, Arnold G. The significance of sonography and computed tomography for the diagnosis of the intraperitoneal spread of tumors. Findings in 307 cases of peritoneal carcinosis. Rofo. 1990;152:516\u201322.","journal-title":"Rofo"},{"key":"357_CR27","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/j.ygyno.2006.06.028","volume":"103","author":"EL Eisenhauer","year":"2006","unstructured":"Eisenhauer EL, Abu-Rustum NR, Sonoda Y, et al. The addition of extensive upper abdominal surgery to achieve optimal cytoreduction improves survival in patients with stages IIIC-IV epithelial ovarian cancer. Gynecol Oncol. 2006;103:1083\u201390.","journal-title":"Gynecol Oncol"},{"issue":"2S1","key":"357_CR28","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.ygyno.2006.10.037","volume":"104","author":"EL Eisenhauer","year":"2007","unstructured":"Eisenhauer EL, Chi DS. Liver mobilization and diaphragm peritonectomy\/resection. Gynecol Oncol. 2007;104(2S1):25\u20138.","journal-title":"Gynecol Oncol"},{"issue":"2S1","key":"357_CR29","first-page":"33","volume":"104","author":"DS Chi","year":"2007","unstructured":"Chi DS, Diaz JP, Jarnagin WR. Distal partial gastrectomy and gastrojejunal anastomosis for recurrent ovarian cancer. Gynecol Oncol. 2007;104(2S1):33\u20136.","journal-title":"Gynecol Oncol"}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-009-0357-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1245\/s10434-009-0357-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-009-0357-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,15]],"date-time":"2020-05-15T22:49:48Z","timestamp":1589582988000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1245\/s10434-009-0357-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,2,19]]},"references-count":29,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2009,5]]}},"alternative-id":["357"],"URL":"https:\/\/doi.org\/10.1245\/s10434-009-0357-0","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,2,19]]}}}